What is the minimum pretransfusion testing requirement for autologous donations collected and transfused by the same facility?

In the case of autologous donations, where the patient donates their own blood to be reinfused at a later date, the minimum pretransfusion testing requirement is primarily focused on ensuring the blood is compatible for transfusion. Since the blood is collected from the individual who will be receiving it, there is a significantly reduced risk of transfusion reactions compared to allogeneic (donor) blood.

ABO and Rh typing are crucial tests that must be performed to confirm the blood type of the patient and ensure that the correct type of blood is being reinfused. This step helps prevent hemolytic transfusion reactions, which could occur if the blood type is mismatched.

In this context, conducting an antibody screen is generally not mandated for autologous donations if the facility has a documented history of compatibility and adequate procedures are in place since the risk is lower. The necessity for a crossmatch may also be omitted under the assumption that the individual’s own blood is being used, eliminating concerns that arise with external donors.

Thus, the appropriate minimum requirement for autologous blood transfusions at the same facility remains ABO and Rh typing.